Intriguingly, both HCC and NMLD groups demonstrated a pronounced inclination towards elevated expressions of several markers, namely CD9, CD41b, CD42a, CD29, and CD31 (Fig. 5). The gene discussed is CD9; the disease is hepatocellular carcinoma.